Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions. (27th May 2014)

• Record Type: Journal Article
• Authors: Cooper-Knock, Johnathan; Walsh, Matthew J.; Higginbottom, Adrian; Robin Highley, J.; Dickman, Mark J.; Edbauer, Dieter; Ince, Paul G.; Wharton, Stephen B.; Wilson, Stuart A.; Kirby, Janine; Hautbergue, Guillaume M.; Shaw, Pamela J.
• Is Part Of: Brain. Volume 137:Part 7(2014:Jul.)
• Page Start: 2040
• Page End: 2051
• Publication Date: 2014-05-27
• Subjects: amyotrophic lateral sclerosis -- pathology -- genetics -- fluorescence imaging; Neurology -- Periodicals; 616.8005
• DOI: 10.1093/brain/awu120
• Languages: English
• ISSNs: 0006-8950

Abstract

Abstract : Expansion of GGGGCC repeats in C9orf72 causes familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia, but the underlying mechanism is unclear. Using RNA pulldown and immunohistochemistry in ALS biosamples, Cooper-Knock et al . identify proteins that bind to the repeat expansions. Disrupted RNA splicing and/or nuclear export may underlie C9orf72 -ALS pathogenesis. Abstract : GGGGCC repeat expansions of C9orf72 represent the most common genetic variant of amyotrophic lateral sclerosis and frontotemporal degeneration, but the mechanism of pathogenesis is unclear. Recent reports have suggested that the transcribed repeat might form toxic RNA foci that sequester various RNA processing proteins. Consensus as to the identity of the binding partners is missing and whole neuronal proteome investigation is needed. Using RNA fluorescence in situ hybridization we first identified nuclear and cytoplasmic RNA foci in peripheral and central nervous system biosamples from patients with amyotrophic lateral sclerosis with a repeat expansion of C9orf72 ( C9orf72 +), but not from those patients without a repeat expansion of C9orf72 ( C9orf72− ) or control subjects. Moreover, in the cases examined, the distribution of foci-positive neurons correlated with the clinical phenotype ( t -test P < 0.05). As expected, RNA foci are ablated by RNase treatment. Interestingly, we identified foci in fibroblasts from an asymptomatic C9orf72 + carrier. We next performed pulldown assays, with GGGGCC5, in conjunction with mass spectrometry analysis, to identify candidate binding partners of the GGGGCC repeat expansion. Proteins containing RNA recognition motifs and involved in splicing, messenger RNA nuclear export and/or translation were significantly enriched. Immunohistochemistry in central nervous system tissue from C9orf72 + patients with amyotrophic lateral sclerosis demonstrated co-localization of RNA foci with SRSF2, hnRNP H1/F, ALYREF and hnRNP A1 in cerebellar granule cells and with SRSF2, hnRNP H1/F and ALYREF in motor neurons, the primary target of pathology in amyotrophic lateral sclerosis. Direct binding of proteins to GGGGCC repeat RNA was confirmed in vitro by ultraviolet-crosslinking assays. Co-localization was only detected in a small proportion of RNA foci, suggesting dynamic sequestration rather than irreversible binding. Additional immunohistochemistry demonstrated that neurons with and without RNA foci were equally likely to show nuclear depletion of TDP-43 (χ 2 P = 0.75) or poly-GA dipeptide repeat protein inclusions (χ 2 P = 0.46). Our findings suggest two non-exclusive pathogenic mechanisms: (i) functional depletion of RNA-processing proteins resulting in disruption of messenger RNA splicing; and (ii) licensing of expanded C9orf72 pre-messenger RNA for nuclear export by inappropriate association with messenger RNA export adaptor protein(s) leading to cytoplasmic repeat associated non-ATG translation and formation of potentially toxic dipeptide repeat protein.